ABOUT US

About Us

Saving Lives Every Day

About Us

Saving Lives Every Day 

The field of addiction treatment has not seen any major diagnostic or treatment advances in over 30 years, until now.

Our geneticists are the pioneers that discovered the DNA mutations that create risk for addiction and behavioral disease. iVitalize is a genetic technology company that has developed groundbreaking genetic diagnostics and solutions for addiction and behavioral disease.

We created a new field of science now taught in medical schools called Reward Deficiency Syndrome (RDS), which is the driver for behavioral disease

We discovered the first gene linked to addiction and behavioral disease driven by Reward Deficiency Syndrome

We have developed neuro-nutrient solutions for behavioral disease and are also developing new technologies that will correct behavioral genetic mutations

Our healthcare visionaries are deploying our portfolio of proprietary genetic solutions to millions of people worldwide

We created GARS (Genetic Addiction Risk Severity), the first and only patented genetic test to identify epigenetic mutation to determine specific behavioral disease in individuals

We created personalized epigenetic neuronutrients to treat behavioral disease

Our scientists are pioneers of new genetic technologies including geneticists from the National Human Genome Center in Washington, DC

We are currently developing solutions for epigenetic behavioral disease

We have some of the industry-leading geneticists developing our technologies and healthcare visionaries bringing our solutions to millions of people around the word

We created a new field of science now taught in medical schools called Reward Deficiency Syndrome (RDS), which is the driver for behavioral disease

We discovered the first gene linked to addiction and behavioral disease driven by Reward Deficiency Syndrome

We have developed neuro-nutrient solutions for behavioral disease and are also developing new technologies that will correct behavioral genetic mutations

Our healthcare visionaries are deploying our portfolio of proprietary genetic solutions to millions of people worldwide

We created GARS (Genetic Addiction Risk Severity), the first and only patented genetic test to identify epigenetic mutation to determine specific behavioral disease in individuals

We created personalized epigenetic neuronutrients to treat behavioral disease

Our scientists are pioneers of new genetic technologies including geneticists from the National Human Genome Center in Washington, DC

We are currently developing solutions for epigenetic behavioral disease

We have some of the industry-leading geneticists developing our technologies and healthcare visionaries bringing our solutions to millions of people around the word

Our Companies

Our Companies

The iVitalize family of companies are at the forefront of genetic technology, working seamlessly toward the goal of Epigenetic Resolution of diseases caused by genetic mutation.

By collaborating and understanding the entire process, from research to delivery, our teams have been able to introduce change and innovation where none has existed for decades. In unison, we excel at helping clinicians and clients save and transform lives.

Our teams have been able to introduce change and innovation

The iVitalize family of companies are at the forefront of genetic technology, working seamlessly toward the goal of Epigenetic Resolution of diseases caused by genetic mutation.

By collaborating and understanding the entire process, from research to delivery, our teams have been able to introduce change and innovation where none has existed for decades. In unison, we excel at helping clinicians and clients save and transform lives.

Our teams have been able to introduce change and innovation

In The News

PHARMA TECH 2018 TOP 10 GENETIC CENTERS

COVER STORY OF SOBER WORLD

COVER STORY OF SOBER WORLD

In The News

PHARMA TECH 2018 TOP 10 GENETIC CENTERS

COVER STORY OF SOBER WORLD

COVER STORY OF SOBER WORLD

Organizations

We have partnered and collaborated with some of the most respected academic and research institutions nationwide and internationally

Organizations

We have partnered and collaborated with some of the most respected academic and research institutions nationwide and internationally

Recent Accomplishments

Recent Accomplishments

“Top 100 Healthcare Visionaries” award from International Forum on Advancements in Healthcare (IFAH)

2015 – 2019 CAP Center of Excellence award

We are one of less than fifty nationally designated genetics labs by Centers for Disease Control and Prevention (CDC)

Funded by the NIH for a new standard of care with GARS Grant # 1R41MD012318-01

GARS accepted for FDA Breakthrough Technology Submission and pending final FDA approval

Awarded multiple VA contracts and received highest quality rating from VA for our molecular testing

2018 Top 10 Innovative Genetic Testing Company (Pharma Tech)

Featured in Sober World magazine, Campus Recovery magazine, Spectrum News, CBS News, and dozens of domestic and international conferences

Collaborative genetic partner with the U.S. National Human Genome Center in Washington, DC

Became first genetic test is U.S history to receive a full patent. Patent # 10,072,289 B2. Patented in over 20 countries globally